Delivery Order SPE2DB20D7059-SPE2DB25FPZY6

Award Date 2/14/25
Potential Completion Date 2/18/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,211.13 delivery order contract is for the supply of 4559304324 - Clindamycin PH 1% Gel 30GM, with a completion date of December 8, 2022. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Clindamycin PH 1% Gel, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,024.82 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop...
This federal contract award, valued at $1,812.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Clindamycin PH 1% Gel, a topical antibiotic medication, with a period of performance through October 2024. The contract is not designated under any set-aside program, indicating open competition. Amerisourcebergen Drug Corp is a for-profit...
This federal contract award is for the delivery of Clindamycin Phosphate 1% Gel, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,175.39 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,349.84 firm fixed-price delivery order (SPE2DB20D1109|SPE2DB24FP90Y) is for the supply of Clindamycin Phosphate 1% Gel, a topical antibiotic medication. The contract has an ultimate completion date of September 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,141.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Clindamycin PH 1% gel, a pharmaceutical product, with a completion date of February 12, 2024. The contract is a firm-fixed-price type and does not have a set-aside designation, indicating it was awarded through full and open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,293.20 Firm Fixed Price Delivery Order is for the provision of clindamycin phosphate 1% gel, with a performance period ending on July 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award is for the delivery of Clindamycin Phosphate 1% Gel, in 30-gram tubes, to the Defense Logistics Agency (DLA). The $1,821.87 Firm Fixed Price Delivery Order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 4, 2024. The contract has an ultimate completion date of January 5, 2024 and was not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,278.92 fixed-price delivery order is for the supply of Clindamycin PH 1% Solution (60 ml), with a completion date of March 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4566752070 - Clindamycin PH 1% Gel 30GM. The contract is a Delivery Order with a Firm Fixed Price of $1,718.19 and has an ultimate completion date of December 19, 2024. The contract is not designated under any set-aside program. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and this award is associated...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FPZY6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,617.13 fixed-price delivery order is for the supply of Clindamycin 1% Gel, 30 grams, to support military healthcare programs.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military globally. The contract has no set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, covering similar medical products and prescription drugs.

Generated 5/16/25, 12:35 PM